CD Biosynsis offers specialized Phaeodactylum tricornutum Multi-Gene Knockout Strain Construction services, providing a high-throughput platform for the simultaneous or sequential disruption of multiple genomic targets. In the complex metabolic landscape of diatoms, many key physiological traits—such as lipid biosynthesis, carbon fixation, and pigment accumulation—are controlled by redundant gene families or parallel enzymatic pathways. A single gene knockout often fails to produce a significant phenotypic shift due to genetic compensation. Our platform utilizes advanced multiplexed CRISPR-Cas9 and Cas12a (Cpf1) systems to bypass these redundancies, enabling the creation of complex mutant libraries and streamlined "clean" chassis strains for marine biotechnology.
Developing multi-gene knockout strains in a diploid organism like Phaeodactylum tricornutum requires sophisticated strategy and execution. Our engineering team leverages DNA-free Ribonucleoprotein (RNP) delivery and specialized episomal vectors to achieve high-efficiency biallelic editing at multiple loci. By using poly-cistronic gRNA arrays and "scarless" editing techniques, we can inactivate entire metabolic branches or eliminate multiple endogenous proteases to improve recombinant protein stability. This systematic approach ensures that the resulting poly-mutant strains are genetically stable, monoclonal, and ready for industrial-scale applications in biofuels, nutraceuticals, and environmental carbon capture.
Get a QuoteThe pennate diatom Phaeodactylum tricornutum frequently exhibits gene duplication events that lead to functional redundancy. To achieve a definitive "null" phenotype for a metabolic pathway, it is often necessary to target 2 to 6 genes simultaneously. Our multi-gene knockout service utilizes optimized nuclease variants and gRNA processing tools, such as the Csy4 endoribonuclease, to ensure balanced and efficient cutting across all targeted loci. This allows for the redirection of carbon flux with unprecedented precision, such as shifting resources from storage carbohydrates to high-value omega-3 fatty acids like EPA.
Our strategic focus is on maintaining cell fitness while maximizing metabolic output. We perform high-resolution flux balance analysis (FBA) to predict the cumulative impact of multiple deletions on cellular growth and stress resilience. Each multi-gene knockout project is treated as a specialized "strain development" program, where clones are screened not only for their genotype but also for their long-term stability and performance in scaled photobioreactors. This rigorous validation ensures that your engineered diatom strain is a reliable platform for both fundamental marine research and commercial-scale biomanufacturing.
We provide a diversified range of strategies to achieve multiple genomic disruptions, depending on the number of targets and the desired final strain configuration.
gRNA Arrays
Delivery of poly-cistronic gRNA cassettes targeting up to 4-6 loci in a single transformation event, utilizing specialized endoribonucleases for efficient guide liberation.
RNP Cocktails
Co-delivery of multiple pre-assembled Cas9-gRNA RNP complexes to achieve immediate biallelic disruption across several genes without the use of DNA vectors.
Marker Recycling
Application of recombinase systems (e.g., Cre-Lox) to excise selection markers between rounds of editing, allowing for an unlimited number of sequential modifications.
Episomal Curing
Utilizing replicative episomes for the CRISPR machinery that can be "cured" or removed from the diatom cell after each round of success, leaving no genomic scars.
Dual-gRNA Flanking
Designing gRNAs to flank large genomic regions or gene clusters to induce a chromosomal deletion, effectively removing entire metabolic subunits in one step.
Chassis Streamlining
Systematic removal of multiple non-essential or inhibitory genes (e.g., cell wall components or proteases) to create a high-performance industrial host.
1. Computational Path Mapping
2. Multiplex Vector/RNP Assembly
3. Transformation & Dual Screening
4. Multi-Allelic Verification
Identification of target paralogs and competitive metabolic branches. Optimization of gRNA spacers for the diatom's nuclear environment and off-target prediction across the entire P. tricornutum genome.
Synthesis of multiplexed gRNA arrays or high-concentration RNP pools. Codon optimization of the nuclease (Cas9 or Cas12a) for maximum translational throughput in diatoms.
Genotyping: Comprehensive verification of all targeted biallelic indels via Next-Generation Sequencing (NGS). Phenotypic Characterization: Assessment of the cumulative metabolic effect (e.g., lipidomics or pigment analysis). Delivery of cryopreserved poly-mutant strains.
Pathway-Scale Disruption
Proven ability to inactivate multiple competitive pathways in a single strain, enabling significant redirection of metabolic resources.
Biallelic Poly-Mutants
We ensure that all target loci in the diploid Phaeodactylum host are modified on both alleles to guarantee a stable and complete phenotype.
RNP Transient Advantage
Use of DNA-free RNPs avoids the metabolic burden and potential off-targets associated with long-term Cas expression and DNA integration.
NGS-Verified Accuracy
Every poly-mutant strain is delivered with full NGS verification of all modified sites, ensuring 100% transparency and genetic definition.
1. How many genes can be knocked out in a single transformation step?
Using our multiplexed gRNA arrays or RNP cocktails, we can typically disrupt 2 to 4 genes simultaneously. For larger-scale engineering, we utilize sequential stacking strategies.
2. How do you handle gene families with high sequence similarity?
We design gRNAs targeting conserved regions to knock out multiple family members at once, or highly specific gRNAs to target individual paralogs without cross-reactivity.
3. Is the growth of the multi-gene mutant strain comparable to wild-type?
This depends on the targeted pathways. We provide comprehensive growth kinetic analysis for all delivered strains to quantify any metabolic burden or growth shifts.
4. Can you perform multi-gene knockouts in industrial diatom isolates?
Yes, we can adapt our transformation and screening protocols for various industrial P. tricornutum isolates beyond the standard lab strains.
5. What is the advantage of using Cas12a for multiplexed editing?
Cas12a (Cpf1) can process its own crRNA arrays from a single transcript, which simplifies the construction of multiplex vectors and often improves the efficiency of multi-site editing.
6. How do you confirm biallelic edits at multiple loci simultaneously?
We utilize targeted deep sequencing (NGS). By analyzing the read frequencies at each locus, we can definitively confirm that both alleles have been disrupted across all target genes.
7. Can you generate "clean" marker-free multi-gene mutants?
Yes, by using RNP delivery or curable episomal vectors, we can provide poly-mutant strains that are free of any permanent antibiotic resistance markers or foreign DNA.
8. What is the typical lead time for a triple knockout project?
A simultaneous triple-knockout project typically takes 16 to 22 weeks, including design, multiple rounds of screening, and comprehensive NGS verification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.